Fuan Kang

Company: MiRecule Inc.

Job title: Vice President - Research

Seminars:

Workshop A: Outlining Progress From Within the Oligonucleotide Conjugate World & Discussing Unique Challenges With Their Development 9:00 am - 12:00 pm

Although the first wave of next-generation conjugates was primarily immunestimulating orientated, there is a growing abundance of oligonucleotide conjugate drugs in development. Conjugating oligonucleotide payloads helps overcome traditional oligonucleotide delivery challenges, but with only a handful of these drugs so far entering the clinic there still is work to do to progress this modality forward.…Read more

day: Pre-Conference Day Track A

Development of Antibody Oligonucleotide Conjugates as Tissue-Targeted RNA Therapies 5:00 pm

Adressing the challenges and potetials of RNA therapies Discussing the development of oligonucleotides and their antibody conjugates as tissue-targeted RNA therapies Introducing the BioCoat technology to improve the delivery of RNA therapiesRead more

day: Scientific Program Day One